All Stories

  1. An unexpected case of Bartonella alsatica prosthetic vascular graft infection
  2. Interaction of Mycoplasma hominis PG21 with Human Dendritic Cells: Interleukin-23-Inducing Mycoplasmal Lipoproteins and Inflammasome Activation of the Cell
  3. Evaluation of a Commercial Multiplex Quantitative PCR (qPCR) Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance-Associated Mutations in Clinical Specimens
  4. Surface lipoproteome of Mycoplasma hominis PG21 and differential expression after contact with human dendritic cells
  5. Molecular Epidemiology of Mycoplasma pneumoniae: Genotyping Using Single Nucleotide Polymorphisms and SNaPshot Technology
  6. Prevalence and Macrolide Resistance of Mycoplasma genitalium in South African Women
  7. Gestion probabiliste des anti-infectieux dans les infections de prothèses vasculaires
  8. Diagnosis of Ureaplasma urealyticum Septic Polyarthritis by PCR Assay and Electrospray Ionization Mass Spectrometry in a Patient with Acute Lymphoblastic Leukemia: FIG 1
  9. COL02-05: Infections à Mycoplasma pneumoniae de l’adulte dans un CHU (2010 à 2012)
  10. Comparison of Mycoplasma pneumoniae Infections in Asthmatic Children Versus Asthmatic Adults
  11. Direct Detection of Macrolide Resistance in Mycoplasma genitalium Isolates from Clinical Specimens from France by Use of Real-Time PCR and Melting Curve Analysis
  12. Evaluation of Two Commercial Real-Time PCR Assays for Detection of Mycoplasma genitalium in Urogenital Specimens
  13. Prevalence of Mycoplasma genitalium Among HIV-Infected Women, Agence Nationale de Recherches sur le SIDA et les hépatites virales CO3 Aquitaine Cohort, France
  14. Identification and Subtyping of Clinically Relevant Human and Ruminant Mycoplasmas by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
  15. P2.048 Evaluation of Two Commercial Real-Time PCR Assays For Detection of Mycoplasma Genitalium in Urogenital Specimens
  16. O06.3 Macrolide Resistance of Mycoplasma Genitalium in France Directly Detected in Clinical Specimens by Real-Time PCR and Melting Curve Analysis
  17. Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection
  18. The increased incidence of Mycoplasma pneumoniae in France in 2011 was polyclonal, mainly involving M. pneumoniae type 1 strains.
  19. Infections à Mycoplasma hominis
  20. Multilocus Variable-Number Tandem-Repeat Analysis-Confirmed Emergence of a Macrolide Resistance-Associated Mutation in Mycoplasma pneumoniae during Macrolide Therapy for Interstitial Pneumonia in an Immunocompromised Child
  21. Detection of macrolide resistance in Mycoplasma genitalium in France
  22. The Spread of Mycoplasma pneumoniae Is Polyclonal in Both an Endemic Setting in France and in an Epidemic Setting in Israel
  23. Clonal Spread of Mycoplasma pneumoniae in Primary School, Bordeaux, France
  24. Mycoplasma pneumoniae: susceptibility and resistance to antibiotics
  25. Development of a real-time PCR targeting the yidC gene for the detection of Mycoplasma hominis and comparison with quantitative culture
  26. Prevalence of Mycoplasma pneumoniae-associated respiratory tract infections in hospitalized children: results of a 4-year prospective study in Tunis
  27. Detection and susceptibility testing of Mycoplasma amphoriforme isolates from patients with respiratory tract infections
  28. First Report of Septic Arthritis Caused by Klebsiella oxytoca
  29. Identification, expression and serological evaluation of the recombinant ATP synthase beta subunit of Mycoplasma pneumoniae
  30. Evaluation of the combination of the NucliSENS easyMAG® and the EasyQ® applications for the detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory tract specimens
  31. Life on Arginine for Mycoplasma hominis: Clues from Its Minimal Genome and Comparison with Other Human Urogenital Mycoplasmas
  32. Syphilis et VIH : à propos de 19 cas de découvertes concomitantes
  33. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis
  34. Evaluation of Five Commercial Real-Time PCR Assays for Detection of Mycoplasma pneumoniae in Respiratory Tract Specimens
  35. Mycoplasmes urogénitaux
  36. Activity of moxifloxacin against the urogenital mycoplasmas Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis
  37. Reduced susceptibility to tetracyclines is associated in vitro with the presence of 16S rRNA mutations in Mycoplasma hominis and Mycoplasma pneumoniae
  38. First Report of Macrolide-Resistant Strains and Description of a Novel Nucleotide Sequence Variation in the P1 Adhesin Gene in Mycoplasma pneumoniae Clinical Strains Isolated in France over 12 Years
  39. Mycoplasmes et chlamydiae: sensibilité et résistance aux antibiotiques
  40. Characterisation of in vitro-selected mutants of Ureaplasma parvum resistant to macrolides and related antibiotics
  41. Mycoplasma spp.
  42. Emergence of a 23S rRNA mutation in Mycoplasma hominis associated with a loss of the intrinsic resistance to erythromycin and azithromycin
  43. Endocardites à Pasteurella sp. Deux cas
  44. Mechanisms of Drug Resistance in Mycoplasma pneumoniae
  45. In Vitro Development of Resistance to Six and Four Fluoroquinolones in Mycoplasma pneumoniae and Mycoplasma hominis, Respectively
  46. Clarithromycin Resistance Associated Gene Mutations
  47. Résistance aux antibiotiques chez les mycoplasmes et les chlamydiae
  48. In Vitro Activities of the Newer Quinolones Garenoxacin, Gatifloxacin, and Gemifloxacin against Human Mycoplasmas
  49. In Vitro Selection and Characterization of Resistance to Macrolides and Related Antibiotics in Mycoplasma pneumoniae
  50. Infections à « Mycoplasma hominis »
  51. DNA Gyrase and Topoisomerase IV Mutations in Clinical Isolates of Ureaplasma spp. and Mycoplasma hominis Resistant to Fluoroquinolones
  52. Strategy of antibiotic rotation: Long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia*
  53. Mutations in 23S rRNA Account for Intrinsic Resistance to Macrolides in Mycoplasma hominis and Mycoplasma fermentans and for Acquired Resistance to Macrolides in M. hominis
  54. In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae
  55. Les mycoplasmes en pathologie humaine
  56. Diagnostic biologique des infections à mycoplasmes